Overview

As more and more advanced therapeutic medicinal products are moving from bench to bedside, the industry is looking to address commercialisation challenges through automation and digitalization. Come join us for an evening to learn more! Wine and nibbles kindly sponsored by Miltenyi Biotec.

Speakers

Miltenyi Biotec (Leading sponsor)

Miltenyi Biotec is a global biotechnology company headquartered near Cologne in Bergisch Gladbach, Germany. The company is a provider of products and services that support scientists, clinical researchers, and physicians across basic research, translational research, and clinical applications. The company offers solutions covering techniques of sample preparation, cell separation, cell sorting, flow cytometry, cell culture, molecular analysis, clinical applications and small animal imaging.

Oxford Biomedica

Oxford Biomedica is a world leader and pioneer in lentiviral vector research, manufacture and clinical development. Oxford Biomedica has over 20 years of experience in the field of gene and cell therapy and are the first organisation to treat humans with in vivo lentiviral based vectors. Using their unique LentiVector® platform they have created a valuable portfolio of gene and cell therapy product candidates for oncological, ophthalmological and CNS indications.

FarmaTrust

FarmaTrust provides future-proof blockchain and AI-based provenance systems for the pharmaceutical and healthcare sector. FarmaTrust digital solutions and services create efficiencies, accountability and transparency for supply chains, ease the burden of compliance requirements, reduce costs and eliminate counterfeit or substandard products.

Scitech

Scitech is a multi-disciplinary design, construction and consultancy company operating predominantly in the Life science, Biotech, ATMP and Pharmaceutical sectors. Scitech activities encompass all stages of project delivery including developing concepts through to full design and built, commissioning and validation. Working closely with small start-ups to major medicine manufacturers, we provide state-of-the-art and bespoke solutions in facility of design and commercialisation  of new therapies. Scitech operates globally from our offices in the UK, Belgium and The Netherlands. 

The material presented has not been peer-reviewed. Any opinions are the presenter's own and do not necessarily represent those of IChemE or the Thames Valley Member Group. The information is given in good faith but without any liability on the part of IChemE.